The medical product supply and manufacturing company Dukal recently went through the process of rebranding with the goal of driving new theories, technology, and outcomes to better serve its end users and distributors.
Repertoire Magazine’s Scott Adams interviewed Charles Abbinanti, President of Dukal, in a podcast on risk mitigation and accelerating innovation within the healthcare industry.
Through outcome-driven approaches, Abbinanti explains how Dukal and industry leaders can employ the “Jobs-To-Be-Done Theory” to break down where the industry is now and where it is heading.